Cargando…
A TLR3 ligand that exhibits potent inhibition of influenza virus replication and has strong adjuvant activity has the potential for dual applications in an influenza pandemic
The appearance and spread of the H5N1 highly pathogenic avian influenza (HPAI) raise concern of a possible pandemic. Current preventive measures include the development of a pre-pandemic influenza vaccine and stockpiling of neuraminidase inhibitors. However, their benefits can be significantly reduc...
Autores principales: | Lau, Yuk-Fai, Tang, Lay-Hoon, Ooi, Eng-Eong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115584/ https://www.ncbi.nlm.nih.gov/pubmed/19150474 http://dx.doi.org/10.1016/j.vaccine.2008.12.048 |
Ejemplares similares
-
In vitro inhibition of human influenza A virus replication by chloroquine
por: Ooi, Eng Eong, et al.
Publicado: (2006) -
The Carbomer-Lecithin Adjuvant Adjuplex Has Potent Immunoactivating Properties and Elicits Protective Adaptive Immunity against Influenza Virus Challenge in Mice
por: Wegmann, Frank, et al.
Publicado: (2015) -
A Formulated TLR7/8 Agonist is a Flexible, Highly Potent and Effective Adjuvant for Pandemic Influenza Vaccines
por: Van Hoeven, Neal, et al.
Publicado: (2017) -
Pretreatment of Epithelial Cells with Live Streptococcus pneumoniae Has No Detectable Effect on Influenza A Virus Replication In Vitro
por: Ouyang, Kang, et al.
Publicado: (2014) -
Economic Analysis of Pandemic Influenza Vaccination Strategies in Singapore
por: Lee, Vernon J., et al.
Publicado: (2009)